Global Pet Biopharmaceuticals Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pet Biopharmaceuticals Market Size 2017-2028

2.1.2 Pet Biopharmaceuticals Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Pet Biopharmaceuticals Segment by Type

2.2.1 Antiparasitic

2.2.2 Biological Products

2.2.3 Antibacterial

2.2.4 Others

2.3 Pet Biopharmaceuticals Market Size by Type

2.3.1 Pet Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Pet Biopharmaceuticals Market Size Market Share by Type (2017-2022)

2.4 Pet Biopharmaceuticals Segment by Application

2.4.1 Prevention

2.4.2 Treatment

2.5 Pet Biopharmaceuticals Market Size by Application

2.5.1 Pet Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Pet Biopharmaceuticals Market Size Market Share by Application (2017-2022)

3 Pet Biopharmaceuticals Market Size by Player

3.1 Pet Biopharmaceuticals Market Size Market Share by Players

3.1.1 Global Pet Biopharmaceuticals Revenue by Players (2020-2022)

3.1.2 Global Pet Biopharmaceuticals Revenue Market Share by Players (2020-2022)

3.2 Global Pet Biopharmaceuticals Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Pet Biopharmaceuticals by Regions

4.1 Pet Biopharmaceuticals Market Size by Regions (2017-2022)

4.2 Americas Pet Biopharmaceuticals Market Size Growth (2017-2022)

4.3 APAC Pet Biopharmaceuticals Market Size Growth (2017-2022)

4.4 Europe Pet Biopharmaceuticals Market Size Growth (2017-2022)

4.5 Middle East & Africa Pet Biopharmaceuticals Market Size Growth (2017-2022)

5 Americas

5.1 Americas Pet Biopharmaceuticals Market Size by Country (2017-2022)

5.2 Americas Pet Biopharmaceuticals Market Size by Type (2017-2022)

5.3 Americas Pet Biopharmaceuticals Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pet Biopharmaceuticals Market Size by Region (2017-2022)

6.2 APAC Pet Biopharmaceuticals Market Size by Type (2017-2022)

6.3 APAC Pet Biopharmaceuticals Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Pet Biopharmaceuticals by Country (2017-2022)

7.2 Europe Pet Biopharmaceuticals Market Size by Type (2017-2022)

7.3 Europe Pet Biopharmaceuticals Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pet Biopharmaceuticals by Region (2017-2022)

8.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2017-2022)

8.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Pet Biopharmaceuticals Market Forecast

10.1 Global Pet Biopharmaceuticals Forecast by Regions (2023-2028)

10.1.1 Global Pet Biopharmaceuticals Forecast by Regions (2023-2028)

10.1.2 Americas Pet Biopharmaceuticals Forecast

10.1.3 APAC Pet Biopharmaceuticals Forecast

10.1.4 Europe Pet Biopharmaceuticals Forecast

10.1.5 Middle East & Africa Pet Biopharmaceuticals Forecast

10.2 Americas Pet Biopharmaceuticals Forecast by Country (2023-2028)

10.2.1 United States Pet Biopharmaceuticals Market Forecast

10.2.2 Canada Pet Biopharmaceuticals Market Forecast

10.2.3 Mexico Pet Biopharmaceuticals Market Forecast

10.2.4 Brazil Pet Biopharmaceuticals Market Forecast

10.3 APAC Pet Biopharmaceuticals Forecast by Region (2023-2028)

10.3.1 China Pet Biopharmaceuticals Market Forecast

10.3.2 Japan Pet Biopharmaceuticals Market Forecast

10.3.3 Korea Pet Biopharmaceuticals Market Forecast

10.3.4 Southeast Asia Pet Biopharmaceuticals Market Forecast

10.3.5 India Pet Biopharmaceuticals Market Forecast

10.3.6 Australia Pet Biopharmaceuticals Market Forecast

10.4 Europe Pet Biopharmaceuticals Forecast by Country (2023-2028)

10.4.1 Germany Pet Biopharmaceuticals Market Forecast

10.4.2 France Pet Biopharmaceuticals Market Forecast

10.4.3 UK Pet Biopharmaceuticals Market Forecast

10.4.4 Italy Pet Biopharmaceuticals Market Forecast

10.4.5 Russia Pet Biopharmaceuticals Market Forecast

10.5 Middle East & Africa Pet Biopharmaceuticals Forecast by Region (2023-2028)

10.5.1 Egypt Pet Biopharmaceuticals Market Forecast

10.5.2 South Africa Pet Biopharmaceuticals Market Forecast

10.5.3 Israel Pet Biopharmaceuticals Market Forecast

10.5.4 Turkey Pet Biopharmaceuticals Market Forecast

10.5.5 GCC Countries Pet Biopharmaceuticals Market Forecast

10.6 Global Pet Biopharmaceuticals Forecast by Type (2023-2028)

10.7 Global Pet Biopharmaceuticals Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Zoetis

11.1.1 Zoetis Company Information

11.1.2 Zoetis Pet Biopharmaceuticals Product Offered

11.1.3 Zoetis Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Zoetis Main Business Overview

11.1.5 Zoetis Latest Developments

11.2 Boehringer Ingelheim

11.2.1 Boehringer Ingelheim Company Information

11.2.2 Boehringer Ingelheim Pet Biopharmaceuticals Product Offered

11.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Boehringer Ingelheim Main Business Overview

11.2.5 Boehringer Ingelheim Latest Developments

11.3 Merck

11.3.1 Merck Company Information

11.3.2 Merck Pet Biopharmaceuticals Product Offered

11.3.3 Merck Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Merck Main Business Overview

11.3.5 Merck Latest Developments

11.4 Elanco

11.4.1 Elanco Company Information

11.4.2 Elanco Pet Biopharmaceuticals Product Offered

11.4.3 Elanco Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Elanco Main Business Overview

11.4.5 Elanco Latest Developments

11.5 Virbac

11.5.1 Virbac Company Information

11.5.2 Virbac Pet Biopharmaceuticals Product Offered

11.5.3 Virbac Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Virbac Main Business Overview

11.5.5 Virbac Latest Developments

11.6 Dechra Veterinary Products

11.6.1 Dechra Veterinary Products Company Information

11.6.2 Dechra Veterinary Products Pet Biopharmaceuticals Product Offered

11.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Dechra Veterinary Products Main Business Overview

11.6.5 Dechra Veterinary Products Latest Developments

11.7 Ceva

11.7.1 Ceva Company Information

11.7.2 Ceva Pet Biopharmaceuticals Product Offered

11.7.3 Ceva Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Ceva Main Business Overview

11.7.5 Ceva Latest Developments

11.8 Vetoquinol

11.8.1 Vetoquinol Company Information

11.8.2 Vetoquinol Pet Biopharmaceuticals Product Offered

11.8.3 Vetoquinol Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Vetoquinol Main Business Overview

11.8.5 Vetoquinol Latest Developments

11.9 Ouro Fino Saude

11.9.1 Ouro Fino Saude Company Information

11.9.2 Ouro Fino Saude Pet Biopharmaceuticals Product Offered

11.9.3 Ouro Fino Saude Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Ouro Fino Saude Main Business Overview

11.9.5 Ouro Fino Saude Latest Developments

11.10 Norbrook

11.10.1 Norbrook Company Information

11.10.2 Norbrook Pet Biopharmaceuticals Product Offered

11.10.3 Norbrook Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Norbrook Main Business Overview

11.10.5 Norbrook Latest Developments

11.11 Jindun

11.11.1 Jindun Company Information

11.11.2 Jindun Pet Biopharmaceuticals Product Offered

11.11.3 Jindun Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Jindun Main Business Overview

11.11.5 Jindun Latest Developments

11.12 Chopperlvya Animal Health

11.12.1 Chopperlvya Animal Health Company Information

11.12.2 Chopperlvya Animal Health Pet Biopharmaceuticals Product Offered

11.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Chopperlvya Animal Health Main Business Overview

11.12.5 Chopperlvya Animal Health Latest Developments

11.13 CAHIC

11.13.1 CAHIC Company Information

11.13.2 CAHIC Pet Biopharmaceuticals Product Offered

11.13.3 CAHIC Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 CAHIC Main Business Overview

11.13.5 CAHIC Latest Developments

12 Research Findings and Conclusion

Table 1. Pet Biopharmaceuticals Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Antiparasitic

Table 3. Major Players of Biological Products

Table 4. Major Players of Antibacterial

Table 5. Major Players of Others

Table 6. Pet Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Pet Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Pet Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 9. Pet Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Pet Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Pet Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 12. Global Pet Biopharmaceuticals Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Pet Biopharmaceuticals Revenue Market Share by Player (2020-2022)

Table 14. Pet Biopharmaceuticals Key Players Head office and Products Offered

Table 15. Pet Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Pet Biopharmaceuticals Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Pet Biopharmaceuticals Market Size Market Share by Regions (2017-2022)

Table 20. Americas Pet Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Pet Biopharmaceuticals Market Size Market Share by Country (2017-2022)

Table 22. Americas Pet Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Pet Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 24. Americas Pet Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Pet Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 26. APAC Pet Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Pet Biopharmaceuticals Market Size Market Share by Region (2017-2022)

Table 28. APAC Pet Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Pet Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 30. APAC Pet Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Pet Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 32. Europe Pet Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Pet Biopharmaceuticals Market Size Market Share by Country (2017-2022)

Table 34. Europe Pet Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Pet Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 36. Europe Pet Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Pet Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Pet Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Pet Biopharmaceuticals

Table 45. Key Market Challenges & Risks of Pet Biopharmaceuticals

Table 46. Key Industry Trends of Pet Biopharmaceuticals

Table 47. Global Pet Biopharmaceuticals Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Pet Biopharmaceuticals Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Pet Biopharmaceuticals Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Pet Biopharmaceuticals Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Pet Biopharmaceuticals Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Pet Biopharmaceuticals Market Size Market Share Forecast by Application (2023-2028)

Table 53. Zoetis Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 54. Zoetis Pet Biopharmaceuticals Product Offered

Table 55. Zoetis Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Zoetis Main Business

Table 57. Zoetis Latest Developments

Table 58. Boehringer Ingelheim Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 59. Boehringer Ingelheim Pet Biopharmaceuticals Product Offered

Table 60. Boehringer Ingelheim Main Business

Table 61. Boehringer Ingelheim Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Boehringer Ingelheim Latest Developments

Table 63. Merck Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 64. Merck Pet Biopharmaceuticals Product Offered

Table 65. Merck Main Business

Table 66. Merck Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Merck Latest Developments

Table 68. Elanco Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 69. Elanco Pet Biopharmaceuticals Product Offered

Table 70. Elanco Main Business

Table 71. Elanco Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Elanco Latest Developments

Table 73. Virbac Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 74. Virbac Pet Biopharmaceuticals Product Offered

Table 75. Virbac Main Business

Table 76. Virbac Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Virbac Latest Developments

Table 78. Dechra Veterinary Products Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 79. Dechra Veterinary Products Pet Biopharmaceuticals Product Offered

Table 80. Dechra Veterinary Products Main Business

Table 81. Dechra Veterinary Products Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Dechra Veterinary Products Latest Developments

Table 83. Ceva Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 84. Ceva Pet Biopharmaceuticals Product Offered

Table 85. Ceva Main Business

Table 86. Ceva Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Ceva Latest Developments

Table 88. Vetoquinol Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 89. Vetoquinol Pet Biopharmaceuticals Product Offered

Table 90. Vetoquinol Main Business

Table 91. Vetoquinol Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Vetoquinol Latest Developments

Table 93. Ouro Fino Saude Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 94. Ouro Fino Saude Pet Biopharmaceuticals Product Offered

Table 95. Ouro Fino Saude Main Business

Table 96. Ouro Fino Saude Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Ouro Fino Saude Latest Developments

Table 98. Norbrook Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 99. Norbrook Pet Biopharmaceuticals Product Offered

Table 100. Norbrook Main Business

Table 101. Norbrook Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Norbrook Latest Developments

Table 103. Jindun Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 104. Jindun Pet Biopharmaceuticals Product Offered

Table 105. Jindun Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Jindun Main Business

Table 107. Jindun Latest Developments

Table 108. Chopperlvya Animal Health Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 109. Chopperlvya Animal Health Pet Biopharmaceuticals Product Offered

Table 110. Chopperlvya Animal Health Main Business

Table 111. Chopperlvya Animal Health Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Chopperlvya Animal Health Latest Developments

Table 113. CAHIC Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors

Table 114. CAHIC Pet Biopharmaceuticals Product Offered

Table 115. CAHIC Main Business

Table 116. CAHIC Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. CAHIC Latest Developments

List of Figures

Figure 1. Pet Biopharmaceuticals Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Pet Biopharmaceuticals Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Pet Biopharmaceuticals Market Size Market Share by Type in 2021

Figure 7. Pet Biopharmaceuticals in Prevention

Figure 8. Global Pet Biopharmaceuticals Market: Prevention (2017-2022) & ($ Millions)

Figure 9. Pet Biopharmaceuticals in Treatment

Figure 10. Global Pet Biopharmaceuticals Market: Treatment (2017-2022) & ($ Millions)

Figure 11. Global Pet Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 12. Global Pet Biopharmaceuticals Revenue Market Share by Player in 2021

Figure 13. Global Pet Biopharmaceuticals Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Pet Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 15. APAC Pet Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 16. Europe Pet Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Pet Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 18. Americas Pet Biopharmaceuticals Value Market Share by Country in 2021

Figure 19. Americas Pet Biopharmaceuticals Consumption Market Share by Type in 2021

Figure 20. Americas Pet Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 21. United States Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Pet Biopharmaceuticals Market Size Market Share by Region in 2021

Figure 26. APAC Pet Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 27. China Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Pet Biopharmaceuticals Market Size Market Share by Country in 2021

Figure 34. Europe Pet Biopharmaceuticals Market Size Market Share by Type in 2021

Figure 35. Europe Pet Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 36. Germany Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 44. Egypt Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Pet Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 50. APAC Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 51. Europe Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 53. United States Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 54. Canada Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 57. China Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 58. Japan Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 59. Korea Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 61. India Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 62. Australia Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 63. Germany Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 64. France Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 65. UK Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 66. Italy Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 67. Russia Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 68. Spain Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 71. Israel Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Pet Biopharmaceuticals Market Size 2023-2028 ($ Millions)